{"id":"https://openalex.org/W7140219504","doi":"https://doi.org/10.1097/01.ccm.0001182872.95130.d7","title":"219: IMPACT OF LOWERED SLIDING-SCALE INSULIN TREATMENT THRESHOLDS ON GLYCEMIC CONTROL","display_name":"219: IMPACT OF LOWERED SLIDING-SCALE INSULIN TREATMENT THRESHOLDS ON GLYCEMIC CONTROL","publication_year":2026,"publication_date":"2026-03-01","ids":{"openalex":"https://openalex.org/W7140219504","doi":"https://doi.org/10.1097/01.ccm.0001182872.95130.d7"},"language":"en","primary_location":{"id":"doi:10.1097/01.ccm.0001182872.95130.d7","doi":"https://doi.org/10.1097/01.ccm.0001182872.95130.d7","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.ccm.0001182872.95130.d7","pdf_url":null,"source":{"id":"https://openalex.org/S108732581","display_name":"Critical Care Medicine","issn_l":"0090-3493","issn":["0090-3493","1530-0293"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Critical Care Medicine","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Abigail Mason","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799342587","display_name":"Erlanger Health System","ror":"https://ror.org/04sz0rs34","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799342587"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Abigail Mason","raw_affiliation_strings":["Erlanger Medical Center, Hixson, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Erlanger Medical Center, Hixson, TN","institution_ids":["https://openalex.org/I2799342587"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022841353","display_name":"Tia E. Collier","orcid":"https://orcid.org/0000-0001-6252-8060","observed_orcids":["https://orcid.org/0000-0001-6252-8060"]},"institutions":[{"id":"https://openalex.org/I2799342587","display_name":"Erlanger Health System","ror":"https://ror.org/04sz0rs34","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799342587"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tia Collier","raw_affiliation_strings":["Erlanger Medical Center, Hixson, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Erlanger Medical Center, Hixson, TN","institution_ids":["https://openalex.org/I2799342587"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5134484922","display_name":"Jessica Briscoe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800717037","display_name":"University of Florida Health","ror":"https://ror.org/04tk2gy88","country_code":"US","type":"education","lineage":["https://openalex.org/I2800717037","https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jessica Briscoe","raw_affiliation_strings":["UF Health Shands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UF Health Shands","institution_ids":["https://openalex.org/I2800717037"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5062619925","display_name":"Breanna Carter","orcid":"https://orcid.org/0000-0002-8872-0015","observed_orcids":["https://orcid.org/0000-0002-8872-0015"]},"institutions":[{"id":"https://openalex.org/I2799342587","display_name":"Erlanger Health System","ror":"https://ror.org/04sz0rs34","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799342587"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Breanna Carter","raw_affiliation_strings":["Erlanger Health System, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Erlanger Health System, TN","institution_ids":["https://openalex.org/I2799342587"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"54","issue":"3S","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11623","display_name":"Hyperglycemia and glycemic control in critically ill and hospitalized patients","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11623","display_name":"Hyperglycemia and glycemic control in critically ill and hospitalized patients","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sliding-scale-insulin","display_name":"sliding scale insulin","score":0.8019999861717224},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.7799999713897705},{"id":"https://openalex.org/keywords/stress-hyperglycemia","display_name":"stress hyperglycemia","score":0.8629999756813049},{"id":"https://openalex.org/keywords/critically-ill-patients","display_name":"critically ill patients","score":0.9190000295639038},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.9120000004768372},{"id":"https://openalex.org/keywords/blood-glucose-target-range","display_name":"blood glucose target range","score":0.6179999709129333},{"id":"https://openalex.org/keywords/intensive-care-unit","display_name":"intensive care unit","score":0.7670000195503235},{"id":"https://openalex.org/keywords/non-critically-ill-patients","display_name":"non-critically ill patients","score":0.7239999771118164},{"id":"https://openalex.org/keywords/insulin-resistance","display_name":"insulin resistance","score":0.41999998688697815}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9847999811172485},{"id":"https://openalex.org/C2780473172","wikidata":"https://www.wikidata.org/wiki/Q5572518","display_name":"Glycemic","level":3,"score":0.8424999713897705},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6272000074386597},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.5389999747276306},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.45210000872612},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.34119999408721924},{"id":"https://openalex.org/C2780352109","wikidata":"https://www.wikidata.org/wiki/Q728309","display_name":"Pancreatic hormone","level":4,"score":0.3188999891281128},{"id":"https://openalex.org/C2909983478","wikidata":"https://www.wikidata.org/wiki/Q186319","display_name":"Triglycerides blood","level":4,"score":0.2630000114440918},{"id":"https://openalex.org/C2780668416","wikidata":"https://www.wikidata.org/wiki/Q202758","display_name":"Hypoglycemia","level":3,"score":0.26109999418258667},{"id":"https://openalex.org/C2986379492","wikidata":"https://www.wikidata.org/wiki/Q1638492","display_name":"Continuous glucose monitoring","level":4,"score":0.2587999999523163}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1097/01.ccm.0001182872.95130.d7","doi":"https://doi.org/10.1097/01.ccm.0001182872.95130.d7","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.ccm.0001182872.95130.d7","pdf_url":null,"source":{"id":"https://openalex.org/S108732581","display_name":"Critical Care Medicine","issn_l":"0090-3493","issn":["0090-3493","1530-0293"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Critical Care Medicine","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2734486075","https://openalex.org/W2034027424","https://openalex.org/W3035145824","https://openalex.org/W2978173342","https://openalex.org/W3185111991","https://openalex.org/W2316903809","https://openalex.org/W2803031491","https://openalex.org/W4399995914","https://openalex.org/W2359748556","https://openalex.org/W4404218183"],"abstract_inverted_index":{"Introduction:":[0],"Stress-induced":[1],"hyperglycemia":[2,27],"is":[3,52],"a":[4,73,107,117,327],"common":[5],"and":[6,17,90,116,146,169,193,306],"significant":[7],"complication":[8],"in":[9,189,195,260,285,336],"critically":[10,89],"ill":[11,92],"patients":[12,93,179,229,243,259],"associated":[13,299],"with":[14,185,267,282,300],"increased":[15,220,235,307],"morbidity":[16],"mortality.":[18],"While":[19],"current":[20],"guidelines":[21],"recommend":[22],"insulin":[23,38,173],"therapy":[24],"for":[25,33,69,112,122,295],"persistent":[26],"\u2265180":[28],"mg/dL,":[29,47],"the":[30,62,66,98,130,155,190,196,200,203,286,292],"optimal":[31],"threshold":[32,68,205,294,329],"administering":[34],"correctional":[35],"sliding":[36],"scale":[37],"(SSI)":[39],"to":[40,60,78,97,212,223,239,251,278],"maintain":[41],"blood":[42],"glucose":[43],"(BG)":[44],"<":[45,160,166],"180":[46],"without":[48],"increasing":[49,275],"hypoglycemic":[50,233],"risk,":[51],"undefined.":[53],"The":[54,126,226],"goal":[55,138,273,337],"of":[56,64,75,132,157,202,228,258,269,288,330],"this":[57],"study":[58,86,99],"was":[59,129,298,313],"evaluate":[61],"impact":[63],"decreasing":[65],"institutional":[67,137],"SSI":[70,95,296,325],"administration":[71,297],"from":[72,177,210,221,237,249,276],"BG":[74,113,123,133,216,270,293],">180":[76,114],"mg/dL":[77,332],">160":[79,124,331],"mg/dL.":[80],"Methods:":[81],"This":[82],"retrospective,":[83],"pre-post":[84],"cohort":[85],"evaluated":[87],"adult":[88],"non-critically":[91],"requiring":[94],"admitted":[96],"institution.":[100],"Patients":[101],"were":[102,183],"divided":[103],"into":[104],"two":[105],"cohorts:":[106],"pre-protocol":[108,191],"group":[109,119,192],"(SSI":[110,120],"administered":[111,121],"mg/dL)":[115],"post-protocol":[118,197],"mg/dL).":[125,151],"primary":[127],"outcome":[128],"percent":[131,227],"values":[134],"falling":[135],"within":[136,218,272],"range":[139,143,148,274],"(70-180":[140],"mg/dL),":[141,145,162,168],"above":[142],"(>180":[144],"below":[147],"(<":[149],"70":[150,161],"Secondary":[152],"outcomes":[153],"included":[154],"incidence":[156],"hypoglycemia":[158,164,247,312],"(BG":[159,165],"severe":[163,246,317],"40":[167],"mean":[170],"total":[171],"daily":[172],"requirement.":[174],"Results:":[175],"Data":[176],"100":[178],"(50":[180],"per":[181],"group)":[182],"collected,":[184],"1,091":[186],"checks":[187,217,271],"analyzed":[188],"1,146":[194],"group.":[198],"Following":[199],"implementation":[201],"reduced":[204,304,328],"SSI,":[206],"hyperglycemic":[207],"episodes":[208],"decreased":[209,248],"63%":[211],"45%":[213],"(p=0.0003),":[214],"while":[215],"goal-range":[219,308],"41%":[222],"57%":[224],"(p=0.0002).":[225],"who":[230,244],"experienced":[231,245],"any":[232],"event":[234],"slightly":[236,314],"8%":[238],"12.5%":[240],"(p=0.505).":[241],"However,":[242],"6%":[250],"4%":[252],"(p=":[253],"0.646).":[254],"A":[255],"subgroup":[256],"analysis":[257],"intensive":[261],"care":[262],"units":[263],"yielded":[264],"similar":[265],"results":[266],"percentage":[268],"52%":[277],"58%":[279],"(p<":[280],"0.001)":[281],"no":[283],"change":[284],"rate":[287],"hypoglycemia.":[289],"Conclusions:":[290],"Lowering":[291],"improved":[301],"glycemic":[302,338],"control,":[303],"hyperglycemia,":[305],"checks.":[309],"Although":[310],"mild":[311],"more":[315],"frequent,":[316],"events":[318],"declined.":[319],"These":[320],"findings":[321],"support":[322],"that":[323],"initiating":[324],"at":[326],"may":[333],"improve":[334],"time":[335],"range.":[339]},"counts_by_year":[],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2026-03-25T00:00:00"}